ETF Managers Group, LLC Infla Rx N.V. Transaction History

ETF Managers Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$1.32 - $3.14 $1,215 - $2,891	-921 Reduced 6.6%	13,044 $34,000
Q2 2022 Aug 15, 2022	BUY	$0.78 - $1.9 $438 - $1,067	562 Added 4.19%	13,965 $20,000
Q1 2022 May 13, 2022	BUY	$1.83 - $4.48 $89 - $219	49 Added 0.37%	13,403 $32,000
Q4 2021 Feb 14, 2022	SELL	$2.35 - $5.58 $6,533 - $15,512	-2,780 Reduced 17.23%	13,354 $59,000
Q3 2021 Nov 15, 2021	BUY	$2.25 - $3.03 $7,206 - $9,705	3,203 Added 24.77%	16,134 $42,000
Q2 2021 Aug 16, 2021	SELL	$2.72 - $4.04 $1,074 - $1,595	-395 Reduced 2.96%	12,931 $38,000
Q1 2021 May 17, 2021	BUY	$3.62 - $6.34 $48,240 - $84,486	13,326 New	13,326 $51,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $99M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.